Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression

Biochemical and Biophysical Research Communications

Volumn 446, Issue 1, 2014, Pages 235-240

  Xu, Hongliang ^a   Wang, Zhaoxia ^a   Jin, Suqin ^a   Hao, Hongjun ^a   Zheng, Lemin ^b   Zhou, Boda ^c   Zhang, Wei ^a   Lv, He ^a   Yuan, Yun ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b BEIJING HOSPITAL   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Cell cycle; Dux4; FSHD; p21

Indexed keywords

DUX 4 PROTEIN; MESSENGER RNA; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; UPREGULATION;

CELL CYCLE; DUX4; FSHD; P21;

BINDING SITES; CELL CYCLE CHECKPOINTS; CELL LINE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; G1 PHASE; HOMEODOMAIN PROTEINS; HUMANS; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84897985382     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.105     Document Type: Article

References (38)

1. J.C. de Greef, R.R. Frants, and S.M. van der Maarel Epigenetic mechanisms of facioscapulohumeral muscular dystrophy Mutat. Res. 647 2008 94 102
2. J.E. Hewitt, R. Lyle, L.N. Clark, E.M. Valleley, T.J. Wright, C. Wijmenga, J.C. van Deutekom, F. Francis, P.T. Sharpe, and M. Hofker et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy Hum. Mol. Genet. 3 1994 1287 1295
3. M. Dixit, E. Ansseau, A. Tassin, S. Winokur, R. Shi, H. Qian, S. Sauvage, C. Matteotti, A.M. van Acker, O. Leo, D. Figlewicz, M. Barro, D. Laoudj-Chenivesse, A. Belayew, F. Coppee, and Y.W. Chen DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1 Proc. Natl. Acad. Sci. USA 104 2007 18157 18162
4. S.M. van der Maarel, R. Tawil, and S.J. Tapscott Facioscapulohumeral muscular dystrophy and DUX4: breaking the silence Trends Mol. Med. 17 2011 252 258
5. L.N. Geng, Z. Yao, L. Snider, A.P. Fong, J.N. Cech, J.M. Young, S.M. van der Maarel, W.L. Ruzzo, R.C. Gentleman, R. Tawil, and S.J. Tapscott DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy Dev. Cell 22 2012 38 51
6. V. Kowaljow, A. Marcowycz, E. Ansseau, C.B. Conde, S. Sauvage, C. Matteotti, C. Arias, E.D. Corona, N.G. Nunez, O. Leo, R. Wattiez, D. Figlewicz, D. Laoudj-Chenivesse, A. Belayew, F. Coppee, and A.L. Rosa The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein Neuromuscul. Disord. 17 2007 611 623
7. L.M. Wallace, S.E. Garwick, W. Mei, A. Belayew, F. Coppee, K.J. Ladner, D. Guttridge, J. Yang, and S.Q. Harper DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo Ann. Neurol. 69 2011 540 552
8. K. Walsh Coordinate regulation of cell cycle and apoptosis during myogenesis Prog. Cell Cycle Res. 3 1997 53 58
9. M.A. Ciemerych, K. Archacka, I. Grabowska, and M. Przewozniak Cell cycle regulation during proliferation and differentiation of mammalian muscle precursor cells Results Probl. Cell Differ. 53 2011 473 527
10. F.E. Stockdale Myogenic cell lineages Dev. Biol. 154 1992 284 298
11. J.B. Miller, L. Schaefer, and J.A. Dominov Seeking muscle stem cells Curr. Top. Dev. Biol. 43 1999 191 219
12. Y.S. Jung, Y. Qian, and X. Chen Examination of the expanding pathways for the regulation of p21 expression and activity Cell. Signal. 22 2010 1003 1012
13. K.H. Vousden, and C. Prives Blinded by the light: the growing complexity of p53 Cell 137 2009 413 431
14. A.L. Gartel, M.S. Serfas, and A.L. Tyner P21-negative regulator of the cell cycle Proc. Soc. Exp. Biol. Med. 213 1996 138 149
15. Z.A. Stewart, and J.A. Pietenpol P53 signaling and cell cycle checkpoints Chem. Res. Toxicol. 14 2001 243 263
16. N.R. Farid P53 and other cell cycle regulators Cancer Treat. Res. 122 2004 149 164
17. E. Senturk, and J.J. Manfredi P53 and cell cycle effects after DNA damage Methods Mol. Biol. 962 2013 49 61
18. A.L. Gartel, and A.L. Tyner Transcriptional regulation of the p21((WAF1/CIP1)) gene Exp. Cell Res. 246 1999 280 289
19. K. Nakano, T. Mizuno, Y. Sowa, T. Orita, T. Yoshino, Y. Okuyama, T. Fujita, N. Ohtani-Fujita, Y. Matsukawa, T. Tokino, H. Yamagishi, T. Oka, H. Nomura, and T. Sakai Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line J. Biol. Chem. 272 1997 22199 22206
20. Y.C. Chew, G. Adhikary, G.M. Wilson, W. Xu, and R.L. Eckert Sulforaphane induction of p21(Cip1) cyclin-dependent kinase inhibitor expression requires p53 and Sp1 transcription factors and is p53-dependent J. Biol. Chem. 287 2012 16168 16178
21. G. Koutsodontis, I. Tentes, P. Papakosta, A. Moustakas, and D. Kardassis Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein J. Biol. Chem. 276 2001 29116 29125
22. M. Richards, F. Coppee, N. Thomas, A. Belayew, and M. Upadhyaya Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum. Genet. 131 2012 325 340
23. L. Snider, L.N. Geng, R.J. Lemmers, M. Kyba, C.B. Ware, A.M. Nelson, R. Tawil, G.N. Filippova, S.M. van der Maarel, S.J. Tapscott, and D.G. Miller Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene PLoS Genet. 6 2010 e1001181
24. V. Sharma, N. Harafuji, A. Belayew, and Y.W. Chen DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells PLoS One 8 2013 e64691
25. J. Gabriels, M.C. Beckers, H. Ding, A. De Vriese, S. Plaisance, S.M. van der Maarel, G.W. Padberg, R.R. Frants, J.E. Hewitt, D. Collen, and A. Belayew Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element Gene 236 1999 25 32
26. F.Q. Alenzi Links between apoptosis, proliferation and the cell cycle Br. J. Biomed. Sci. 61 2004 99 102
27. C.H. Golias, A. Charalabopoulos, and K. Charalabopoulos Cell proliferation and cell cycle control: a mini review Int. J. Clin. Pract. 58 2004 1134 1141
28. G. Liu, and G. Lozano P21 stability: linking chaperones to a cell cycle checkpoint Cancer Cell 7 2005 113 114
29. T. Abbas, and A. Dutta P21 in cancer: intricate networks and multiple activities Nat. Rev. Cancer 9 2009 400 414
30. N. Abdel-Wahab, B.S. Weston, T. Roberts, and R.M. Mason Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy J. Am. Soc. Nephrol. 13 2002 2437 2445
31. R. Li, S. Waga, G.J. Hannon, D. Beach, and B. Stillman Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair Nature 371 1994 534 537
32. S. Waga, G.J. Hannon, D. Beach, and B. Stillman The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA Nature 369 1994 574 578
33. L. Li, and J.R. Davie The role of Sp1 and Sp3 in normal and cancer cell biology Ann. Anat. 192 2010 275 283
34. M. Ocker, and R. Schneider-Stock Histone deacetylase inhibitors: signalling towards p21cip1/waf1 Int. J. Biochem. Cell Biol. 39 2007 1367 1374
35. M.B. Datto, Y. Yu, and X.F. Wang Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter J. Biol. Chem. 270 1995 28623 28628
36. H. Amthor, B. Christ, M. Weil, and K. Patel The importance of timing differentiation during limb muscle development Curr. Biol. 8 1998 642 652
37. J.J. Dore, J.C. DeWitt, N. Setty, M.D. Donald, E. Joo, M.A. Chesarone, and S.J. Birren Multiple signaling pathways converge to regulate bone-morphogenetic-protein-dependent glial gene expression Dev. Neurosci. 31 2009 473 486
38. G.A. Wong, V. Tang, F. El-Sabeawy, and R.H. Weiss BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1 Am. J. Physiol. Endocrinol. Metab. 284 2003 E972 E979